Treatment atrial fibrillation after ?coronary artery bypass grafting

Comparison of Amiodarone versus Metoprolol in treating atrial fibrillation after ?coronary artery bypass grafting

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT2017010920258N26

Enrollment

146

Registered

2017-02-23

Start date

2015-12-22

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

atrial fibrillation. Atrial fibrillation and flutter

Interventions

Intervention 1: Intervention group 1: We prescribed 300 milligram ?Amiodarone state and 1 milligram per kilogram Amiodarone in the first 6 ?hours and then 0.5 milligram per ?kilogram Amiodarone for th

Treatment - Drugs

Intervention group 1: We prescribed 300 milligram ?Amiodarone state and 1 milligram per kilogram Amiodarone in the first 6 ?hours and then 0.5 milligram per ?kilogram Amiodarone for the next 18 hours

Intervention group 2: We prescribed 1-3 ?milligram per kilogram ?per hours Metoprolol for the first 24 hours after surgery in Metoprolol group.

Eligibility

Sex/Gender

All

Age

45 Years to 80 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: patients undergoing coronary artery bypass graft; being at the age of 45-80 years; absence of ??coronary artery ?surgery history; absence of atrial fibrillation history; not being anti Arrhythmia consumer.? Exclusion criteria: patients who need defibrillation treatment; need surgery other than ?coronary ?artery bypass graft; patients who need urgency coronary artery bypass grafting.?

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Atrial fibrillation. Timepoint: After surgery. Method of measurement: ECG.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Alireza Kamali

Arak University of Medical Sciences

alikamaliir@yahoo.com+98 86 3222 2003

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026